The bone, the joints and the balm of gilead

Molecular Pharmaceutics

Volumn 8, Issue 4, 2011, Pages 991-993

  Wang, Dong ^a   Goldring, Steven R ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; DEXAMETHASONE; HYDROXYAPATITE; LIPOSOME; MACROGOL; N (2 HYDROXYPROPYL)METHACRYLAMIDE; PACLITAXEL; SIMVASTATIN; SMALL INTERFERING RNA;

ARTHRITIS; BONE METASTASIS; BONE REGENERATION; BONE REMODELING; BREAST CANCER; DRUG DELIVERY SYSTEM; DRUG DESIGN; HUMAN; JOINT CAVITY; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL SYSTEM; NONHUMAN; OSTEOARTHRITIS; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM;

BONE AND BONES; HUMANS; JOINTS; MUSCULOSKELETAL DISEASES;

EID: 79961036952     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200328t     Document Type: Review

References (18)

1. Posner, A. S. Crystal chemistry of bone mineral Physiol. Rev. 1969, 49, 760-92
2. Marks, S. C., Jr.; Odgren, P. R. Structure and Development of the Skeleton. In Bilezikian, J. P.; Raisz, L. G.; Rodan, G. A., Eds.; Principles of Bone Biology, 2 nd ed.; Academic Press: San Diego, 2002; pp 3-15.
3. Goldring, S. R.; Goldring, M. B. Biology of the Normal Joint. In Kelly's Text Book Rheumatology, 8 th ed.; Firestein, G. S.; Budd, R. C.; Harris, E. D., Jr.; McInnes, I. B.; Ruddy, S.; Sergent, J. S., Eds.; Saunders Elsevier: Philadelphia, 2009; pp 1-22.
4. Rodan, G. A.; Martin, T. J. Therapeutic approaches to bone diseases Science 2000, 289, 1508-14
5. Wang, D.; Miller, S. C.; Kopeček, J. Targeted drug delivery for musculoskeletal diseases Adv. Drug Delivery Rev. 2005, 57, 935-7 (Pubitemid 40692285)
6. van den Hoven, J. M.; Van Tomme, S. R.; Metselaar, J. M.; Nuijen, B.; Beijnen, J. H.; Storm, G. Liposomal drug formulations in the treatment of rheumatoid arthritis Mol. Pharmaceutics 2011, 10.1021/mp2000742
7. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 1986, 46, 6387-92 (Pubitemid 17221789)
8. Quan, L. D.; Purdue, P. E.; Liu, X. M.; Boska, M. D.; Lele, S. M.; Thiele, G. M.; Mikuls, T. R.; Dou, H.; Goldring, S. R.; Wang, D. Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy Arthritis Res. Ther. 2010, 12, R170
9. Metselaar, J. M.; van den Berg, W. B.; Holthuysen, A. E.; Wauben, M. H.; Storm, G.; van Lent, P. L. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis Ann. Rheum. Dis. 2004, 63, 348-53 (Pubitemid 38453298)
10. Fiehn, C.; Muller-Ladner, U.; Gay, S.; Krienke, S.; Freudenberg-Konrad, S.; Funk, J.; Ho, A. D.; Sinn, H.; Wunder, A. Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX Rheumatology (Oxford) 2004, 43, 1097-105 (Pubitemid 39232813)
11. Ren, K.; Purdue, P. E.; Burton, L.; Quan, L.-d.; Fehringer, E. V.; Geoffrey M.Thiele, G. M.; Goldring, S. R.; Wang, D. Early detection and treatment of wear particle-induced inflammation and bone loss in a mouse calvarial osteolysis model using HPMA copolymer conjugates Mol. Pharmaceutics 2011, 10.1021/mp2000555
12. Toh, W. S.; Spector, M.; Lee, E. H.; Cao, T. Biomaterial-mediated delivery of microenvironmental cues for repair and regeneration of articular cartilage Mol. Pharmaceutics 2011, 10.1021/mp100437a
13. Wang, G.; Babadaǧli, M. E.; Uludaǧ, H. Bisphosphonate- derivatized liposomes to control drug release from collagen/hydroxyapatite scaffolds Mol. Pharmaceutics 2011, 10.1021/mp200028w
14. Lee, Y.; Liu, X.; Nawshad, A.; Marx, D. B.; Wang, D.; Reinhardt, R. A. Role of prostaglandin pathway and alendronate-based carriers to enhance statin-induced bone Mol. Pharmaceutics 2011, 10.1021/mp200045p
15. Wang, Y.; Panasiuk, A.; Grainger, D. W. Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures Mol. Pharmaceutics 2011, 10.1021/mp100374n
16. Miller, K.; Eldar-Boock, A.; Polyak, D.; Segal, E.; Benayoun, L.; Shaked, Y.; Satchi-Fainaro, R. Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model Mol. Pharmaceutics 2011, 10.1021/mp200083n
17. Clementi, C.; Miller, K.; Mero, A.; Satchi-Fainaro, R.; Pasut, G. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms Mol. Pharmaceutics 2011, 10.1021/mp2001445
18. Official website of US Bone and Joint Decade: http://www.usbjd.org/.